Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23330092)

  • 1. Expression of genes of glutathione transferase isoforms GSTP1-1, GSTA4-4, and GSTK1-1 in tumor cells during the formation of drug resistance to cisplatin.
    Kalinina EV; Berozov TT; Shtil AA; Chernov NN; Glasunova VA; Novichkova MD; Nurmuradov NK
    Bull Exp Biol Med; 2012 Nov; 154(1):64-7. PubMed ID: 23330092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of genes for redox-dependent glutathione S-transferase isoforms GSTP1-1 and GSTA4-4 in tumor cell during the development doxorubicin resistance.
    Kalinina EV; Chernov NN; Saprin AN; Kotova YN; Remizov VI; Shcherbak NP
    Bull Exp Biol Med; 2007 Mar; 143(3):328-30. PubMed ID: 18225754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
    Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
    Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation.
    Kalinina EV; Berezov TT; Shtil' AA; Chernov NN; Glazunova VA; Novichkova MD; Nurmuradov NK
    Bull Exp Biol Med; 2012 Oct; 153(6):878-81. PubMed ID: 23113308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors.
    Mavis CK; Morey Kinney SR; Foster BA; Karpf AR
    Prostate; 2009 Sep; 69(12):1312-24. PubMed ID: 19444856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
    Cheng G; Li Y; Tian F
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
    Yang M; Li Y; Shen X; Ruan Y; Lu Y; Jin X; Song P; Guo Y; Zhang X; Qu H; Shao Y; Quan C
    J Exp Clin Cancer Res; 2017 Nov; 36(1):157. PubMed ID: 29116019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines.
    Sawers L; Ferguson MJ; Ihrig BR; Young HC; Chakravarty P; Wolf CR; Smith G
    Br J Cancer; 2014 Sep; 111(6):1150-8. PubMed ID: 25010864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein protects human mammary epithelial cells from benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide and 4-hydroxy-2-nonenal genotoxicity by modulating the glutathione/glutathione S-transferase system.
    Steiner C; Peters WH; Gallagher EP; Magee P; Rowland I; Pool-Zobel BL
    Carcinogenesis; 2007 Mar; 28(3):738-48. PubMed ID: 17065199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells.
    Goto S; Iida T; Cho S; Oka M; Kohno S; Kondo T
    Free Radic Res; 1999 Dec; 31(6):549-58. PubMed ID: 10630679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.
    Nishiyama M; Yamamoto W; Park JS; Okamoto R; Hanaoka H; Takano H; Saito N; Matsukawa M; Shirasaka T; Kurihara M
    Clin Cancer Res; 1999 Sep; 5(9):2620-8. PubMed ID: 10499641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
    Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
    Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1.
    Zhang X; Zhu J; Xing R; Tie Y; Fu H; Zheng X; Yu B
    Lung Cancer; 2012 Sep; 77(3):488-94. PubMed ID: 22749944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling.
    Zhang Y; Qu X; Jing W; Hu X; Yang X; Hou K; Teng Y; Zhang J; Liu Y
    Anticancer Drugs; 2009 Mar; 20(3):208-14. PubMed ID: 19396019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy of adenovirus mediated CD ::upp/5-FC directed by GSTP1 promoter in cisplatin-resistant ovarian cancer.
    Wang Z; Cai L; Wang H
    Gynecol Oncol; 2005 Mar; 96(3):643-50. PubMed ID: 15721406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
    Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
    Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.